Myocarditis as a prognostic indicator in systemic lupus erythematosus

Postgraduate Medical Journal

Volumn 80, Issue 944, 2004, Pages 366-367

  Busteed, S ^a   Sparrow, P ^b   Molloy, C ^b   Molloy, M G ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYCLOPHOSPHAMIDE; DIGOXIN; ENALAPRIL; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MEDICAL EXAMINATION; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PROGNOSIS; RELAPSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOCARDITIS; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3042686859     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2003.012450     Document Type: Review

References (14)

1. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
2. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002;113:419-23.
3. Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9.
4. Kim WU, Min JK, Lee SH, et al. Causes of death in Korean patients with systemic lupus erythematosus: a single centre retrospective study. Clin Exp Rheumatol 1999;17:539-45.
5. Frustaci A, Gentiloni N, Caldarulo M. Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 1996;109:282-4.
6. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
7. Logar D, Kveder T, Rozman B, et al. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 1990;49:627-9.
8. Swaak AJ, Huysen V, Smeenk RJ. Antinuclear antibodies in routine analysis: the relevance of putative clinical associations. Ann Rheum Dis 1993;52:110-4.
9. Morguet AJ, Sandrock D, Stille-Siegener M, et al. Indium-11 1-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus. J Nucl Med 1995;36:1432-5.
10. Ueda T. Echocardiographic observation of acute myocarditis with systemic lupus erythematosus. Jpn Circ J 2000;64:144-6.
11. Hammann C, Genton CY, Delabays A, et al. Myocarditis of mixed connective tissue disease: favourable outcome after intravenous pulsed cyclophosphamide. Clin Rheumatol 1999;18:85-7.
12. Sherer Y, Levy Y, Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 1999;18:238-40.
13. Tamburino C, Fiore CE, Foti R, et al. Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE). Clin Rheumatol 1989;8:108-12.
14. Leung MC, Harper RW, Boxall J. Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus. Med J Aust 2002;176:374-5.